Publications

Dual inhibition of ACLY and ACSS2 by EVT0185 reduces steatosis, hepatic stellate cell activation, and fibrosis in mouse models of MASH

 52
Dual inhibition of ACLY and ACSS2 by EVT0185 reduces steatosis, hepatic stellate cell activation, and fibrosis in mouse models of MASH

Tags:

Previous Article

Blood test can to identify cancer in patients with non-specific symptoms

Next Article

New drug candidate reverses metabolic liver disease and fibrosis

Related Posts

Recessive epistasis of a synonymous mutation confers cucumber domestication through epitranscriptomic regulation

Recessive epistasis of a synonymous mutation confers cu...

 80

Structural basis of μ-opioid receptor targeting by a nanobody antagonist

Structural basis of μ-opioid receptor targeting by a na...

 98

More than just membranes: membrane contact sites as crossroads for infections

More than just membranes: membrane contact sites as cro...

 49